Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 DSP-5423P (blonanserin transdermal patch) in patients with schizophrenia
jRCT2080222637Phase 3Completed
- Sponsor
- Sumitomo Pharma
- Start
- Oct 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of Blonanserin transdermal patch in schizophrenia (3 arms), sponsored by Sumitomo Pharma. Started Oct 2014; status: completed.
02
Drugs
Blonanserin transdermal patch
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080222637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222637.